Form 10-Q PharMerica CORP For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Pharmerica (PMC) Tops Q3 EPS by 5c; Boosts FY14 Outlook
November 6, 2014 8:23 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $470.2 million versus the consensus estimate of $439.63 million.
Pharmerica sees FY2014 EPS of $1.62-$1.64, versus prior guidance of $1.58-$1.62 and the consensus of $1.59. Pharmerica sees... More
